Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel J. Cua is active.

Publication


Featured researches published by Daniel J. Cua.


Archive | 2006

Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis Silver; Dror Luger


Archive | 2004

Uses of il-23 related reagents

Daniel J. Cua; Yi Chen; Robert A. Kastelein; Claire L. Langrish; Donna M. Rennick; Jonathon Sedgwick


Archive | 2013

Absence of IL-12 Resistance to Acute Toxoplasmosis in the IL-23 Provides a Limited Mechanism of

Christopher A. Hunter; Donna M. Rennick; Daniel J. Cua; A. Lieberman; Fabíola Cardillo


Archive | 2008

Kombinationstherapie zur Behandlung von Immunerkrankungen

Edward P. Bowman; Daniel J. Cua; Robert A. Kastelein; Kathy Lynn Miller; Melanie A. Kleinschek; Kristian Sass Bak-Jensen; Katia Boniface; Brent S. McKenzie; Waal Malefyt Rene De


Archive | 2008

Polythérapie pour le traitement de maladies immunes

Edward P. Bowman; Daniel J. Cua; Robert A. Kastelein; Kathy Lynn Miller; Melanie A. Kleinschek; Kristian Sass Bak-Jensen; Katia Boniface; Brent S. McKenzie; Waal Malefyt Rene De


Archive | 2006

Utilisation des antagonistes IL-23 et IL-17 pour traiter la maladie inflammatoire oculaire auto-immune

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger


Archive | 2006

Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung Use of IL-23 and IL-17 antagonists for the treatment of autoimmune inflammatory eye disease

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger


Archive | 2006

Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger


Archive | 2006

Verwendung von IL-23- und IL-17-Antagonisten zur Behandlung von Augenentzündungsautoimmunerkrankungen

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger


Archive | 2006

Uso de antagonistas de il-23 e il-17 para tratar la enfermedad inflamatoria ocular autoinmunologica.

Rachel Caspi; Daniel J. Cua; Robert A. Kastelein; Dror Luger; Phyllis B. Silver; Van T. Tsai

Collaboration


Dive into the Daniel J. Cua's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dror Luger

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Phyllis B. Silver

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge